scholarly journals EFFICIENCY OF PHARMACEUTICAL CONSUMPTION IN TURKEY: BENCHMARKING WITH OECD BY DEA

2018 ◽  
Vol 6 (3) ◽  
Author(s):  
Çağla Pınar BOZOKLU ◽  
Yasemin KESKİN BENLİ
Keyword(s):  
Private Health Insurance ◽  
Returns To Scale ◽  
Oecd Countries ◽  
Pharmaceutical Products ◽  
Total Efficiency ◽  
Public And Private ◽  
Pharmaceutical Consumption ◽  
Natural Outcome ◽  
Variable Returns To Scale ◽  
Consumption Efficiency

After 1980s, consumers begin to focus more health-conscious behaviours and attitudes including the concept of consuming pharmaceutical products. Pharmaceutical consumption attitude is a natural outcome of this trend. In this research, it is aimed to analyze Turkey’s benchmarking position among OECD countries in terms of pharmaceutical consumption efficiency. 15 OECD countries’ 5 years (2008-2012) analyzed by DEA-Malmquist TFP with the output-oriented and variable returns to scale methods. TC index shows that Turkey had created more pharmaceutical consumption and longer life expectancy by using same amount of number of physicians, number of pharmacists, total public and private health insurance expenditures and number of doctor consultations. By the way, Turkey had embraced efficiency growth with the rate of 0.4 percent. However, total efficiency level of Turkey got damaged by reason of its administrative limitations.

scholarly journals EFFICIENCY OF PHARMACEUTICAL CONSUMPTION IN TURKEY: BENCHMARKING WITH OECD BY DEA

2018 ◽  
Vol 6 (3) ◽  
pp. 253-262
Author(s):  
Çağla Pınar BOZOKLU ◽  
Yasemin KESKİN BENLİ
Keyword(s):  
Private Health Insurance ◽  
Returns To Scale ◽  
Oecd Countries ◽  
Pharmaceutical Products ◽  
Total Efficiency ◽  
Public And Private ◽  
Pharmaceutical Consumption ◽  
Natural Outcome ◽  
Variable Returns To Scale ◽  
Consumption Efficiency

After 1980s, consumers begin to focus more health-conscious behaviours and attitudes including the concept of consuming pharmaceutical products. Pharmaceutical consumption attitude is a natural outcome of this trend. In this research, it is aimed to analyze Turkey’s benchmarking position among OECD countries in terms of pharmaceutical consumption efficiency. 15 OECD countries’ 5 years (2008-2012) analyzed by DEA-Malmquist TFP with the output-oriented and variable returns to scale methods. TC index shows that Turkey had created more pharmaceutical consumption and longer life expectancy by using same amount of number of physicians, number of pharmacists, total public and private health insurance expenditures and number of doctor consultations. By the way, Turkey had embraced efficiency growth with the rate of 0.4 percent. However, total efficiency level of Turkey got damaged by reason of its administrative limitations.

scholarly journals Self-Rated Health Status Based on the Type of Health Insurance: A Socioeconomic Perspective

2021 ◽  
Vol 58 ◽  
pp. 004695802110281
Author(s):  
Minsung Sohn ◽  
Minsoo Jung ◽  
Mankyu Choi
Keyword(s):  
Socioeconomic Status ◽  
Health Insurance ◽  
Health Status ◽  
Regression Models ◽  
Private Health Insurance ◽  
Public And Private ◽  
Logistic Regression Models ◽  
Self Rated Health ◽  
Interaction Terms ◽  
Healthcare Coverage

To investigate the effects of public and private health insurance on self-rated health (SRH) status within the National Health Insurance (NHI) system based on socioeconomic status in South Korea. The data were obtained from 10 867 respondents of the Korea Health Panel (2008-2011). We used hierarchical panel logistic regression models to assess the SRH status. We also added the interaction terms of socioeconomic status and type of health insurance as moderators. Medical aid (MA) recipients were 2.10 times more likely to have a low SRH status than those who were covered only by the NHI, even though the healthcare utilization was higher. When the interaction terms were included, those not covered by the NHI and had completed elementary school or less were 16.59 times more likely to have a low SRH status than those covered by the NHI and had earned a college degree or higher. Expanding healthcare coverage to reduce the burden of non-payment and unmet use to improve the health status of MA beneficiaries should be considered. Particularly, the vulnerability of less-educated groups should be focused on.

scholarly journals Building inclusive health innovation systems: lessons from India

2016 ◽  
Vol 32 (suppl 2) ◽  
Author(s):  
Dinesh Abrol ◽  
T. Sundararaman ◽  
Harilal Madhavan ◽  
K. J. Joseph
Keyword(s):  
Policy Development ◽  
National Level ◽  
Innovation System ◽  
Pharmaceutical Products ◽  
Innovation Systems ◽  
Public And Private ◽  
Health Innovation ◽  
Medical Institutions ◽  
The Government ◽  
Delivery Of Medical Care

Abstract: This article presents an overview of the changes that are taking place within the public and private health innovation systems in India including delivery of medical care, pharmaceutical products, medical devices, and Indian traditional medicine. The nature of the flaws that exist in the health innovation system is pinpointed. The response by the government, the health, technology and medical institutions, and the evolving industry is addressed on a national level. The article also discusses how the alignment of policies and institutions was developed within the scope of national health innovation systems, and how the government and the industry are dealing with the challenges to integrate health system, industry, and social policy development processes.

Sign in / Sign up

Export Citation Format

Share Document